US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
FDA Reversal on Knockoff GLP-1 Drugs Brings Confusion, and Few Answers
A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...
12-year-old is first kid in SD to delay Type 1 diabetes with new drug
Thousands of Americans are diagnosed with Type 1 diabetes every year, according to the American Diabetes Association. But a ...
Investor's Business Daily on MSN59 分钟
Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record
Lundbeck announced Monday it would buy Longboard Pharmaceuticals in a $2.6 billion deal that sent Longboard stock to a record ...
SchaeffersResearch.com51 分钟
FDA Buzz Sends Health and Wellness Stock Surging
Hims & Hers Health (HIMS) is enjoying a morning surge after the Food and Drug Administration (FDA) dropped fresh news ...
Food Safety News12 小时
FDA cracks down on food importers for major safety violations
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
STAT2 天
In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...
FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
policymed.com7 小时
Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating Cancer Drug Efficacy
Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter to Mirati Therapeutics for claims made by the ...
The Times of Northwest Indiana2 小时
Get Healthy: Hot Topics: Nasal allergy treatment, exercise timing, 'stealth'' sugar and fat ...
The spray, sold under the brand Neffy, is a single-dose nasal spray and is approved in adults and children who weigh 66 ...
STAT5 天
Q&A: How the FDA is approaching AI in clinical trials and drug development
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
stockhead on MSN13 小时
Imricor eyes worldwide expansion with progress on US and EU regulatory approval
Imricor Medical Systems (ASX:IMR) is racing through regulatory initiatives supporting new device approvals in the US and ...